Research into the presence of the toxic substance PFAS in the blood of people living in contaminated areas in Flanders is being expanded: until now, only people living near the 3M plant in Zwijndrecht were examined, but the area is now being broadened.
While the recent news of PFAS in the Vivaqua network has brought on numerous concerns over pollution in Brussels tap water, the ongoing testing to trace the chemicals in people's blood across Flanders will now include more areas.
"We find that there is concern among people living near industrial sites and incinerators, for example, about the possible presence of PFAS in their bodies," Flemish Welfare Minister Hilde Crevits said in a press release. "That is why scientific research will be expanded."
Blood tests and surveys
Currently, people living within a five-kilometre radius of the 3M plant in Zwijndrecht can have their blood tested, but studies will now also follow in other places; PFAS contamination has also been detected in nearby municipalities such as Ronse and Beringen.
"Next year, there will be a preliminary scientific study to determine which regions are still eligible," Crevits said. "That could include sites around fire stations, around industrial sites, and the area around incinerators."
Once the list of exact locations is established, the actual research can begin. Blood will be drawn from residents, but they will also be given questionnaires to fill in.
Related News
- PFAS in tap water is only 'tip of the chemical pollution iceberg’
- High concentrations of most dangerous PFAS for half of Brussels residents
- PFAS pollution in tap water: Brussels open to new 'overly-cautious' measures
"We also want to know what the impact is on the mental wellbeing and anxiety of people living in areas where there is PFAS contamination," said Crevits. "So it is not just some blood sampling: this is done under scientific guidance."
The exact locations for the study will be determined in the coming months, and blood sampling and analysis will take place in 2025. Results are expected in the same year. A sum of €1.8 million will be released for the research.
